These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9584851

  • 1. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.
    Gumińska M, Ignacak J, Kedryna T, Stachurska MB.
    Acta Biochim Pol; 1997; 44(4):711-24. PubMed ID: 9584851
    [Abstract] [Full Text] [Related]

  • 2. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S.
    Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
    [Abstract] [Full Text] [Related]

  • 3. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
    Spoden GA, Rostek U, Lechner S, Mitterberger M, Mazurek S, Zwerschke W.
    Exp Cell Res; 2009 Oct 01; 315(16):2765-74. PubMed ID: 19563799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors.
    Eigenbrodt E, Leib S, Krămer W, Friis RR, Schoner W.
    Biomed Biochim Acta; 1983 Oct 01; 42(11-12):S278-82. PubMed ID: 6326772
    [Abstract] [Full Text] [Related]

  • 7. The tumor metabolome.
    Mazurek S, Eigenbrodt E.
    Anticancer Res; 2003 Oct 01; 23(2A):1149-54. PubMed ID: 12820363
    [Abstract] [Full Text] [Related]

  • 8. Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF.
    Schmidt M, Kammerer U, Segerer S, Cramer A, Kohrenhagen N, Dietl J, Voelker HU.
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul 01; 139(1):72-8. PubMed ID: 18394773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW, Petri E, Bichler KH, Feil G.
    Anticancer Res; 1999 Jul 01; 19(4A):2583-90. PubMed ID: 10470199
    [Abstract] [Full Text] [Related]

  • 13. Electrophoretic pattern of cytosolic pyruvate kinase fractions A and B (type L and M2) from normal rat liver and Morris hepatoma 7777.
    Gumińska M, Ignacak J.
    Biochim Biophys Acta; 1996 Jan 04; 1292(1):99-105. PubMed ID: 8547355
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of pyruvate kinase variants from rat liver and Morris hepatoma 7777, obtained by an affinity chromatography on blue sepharose CL-6B.
    Ignacak J, Gumińska M.
    Acta Biochim Pol; 1993 Jan 04; 40(2):261-7. PubMed ID: 8212964
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cancer metabolism: When more is less.
    Jiang L, Deberardinis RJ.
    Nature; 2012 Sep 27; 489(7417):511-2. PubMed ID: 23018962
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.